Schrodinger: Schrdinger's stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
Schrödinger will receive $150 million upfront plus up to $2.3 billion in milestone and royalty payments.
Read full article »
Schrodinger is a New York-based chemical simulation software that offers solutions such as drug design and molecular modeling for pharmaceutical and biotechnology companies.
Read more